Viewing Study NCT06351020


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-02-27 @ 8:49 AM
Study NCT ID: NCT06351020
Status: RECRUITING
Last Update Posted: 2025-09-12
First Post: 2024-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.
Sponsor: LaNova Medicines Zhejiang Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module